SlideShare a Scribd company logo
1 of 80
Community Responses to Heroin:
North Carolina and Northern Kentucky
Presenters:
• Kim Moser, Director, Northern Kentucky Office of Drug Control
• Scott Proescholdbell, MPH, Epidemiologist, Injury and Violence
Prevention Branch, North Carolina Department of Health and Human
Services
• Nidhi Sachdeva, MPH, Injury Prevention Consultant, Division of Public
Health, North Carolina Department of Health and Human Services
Heroin Track
Moderator: Kelly J. Clark, MD, MBA, FASAM, DFAPA, President-elect,
American Society of Addiction Medicine, and Member, Rx and Heroin
Summit National Advisory Board
Disclosures
• Scott Proescholdbell, MPH; Nidhi Sachdeva,
MPH; and Kelly J. Clark, MD, MBA, FASAM,
DFAPA, have disclosed no relevant, real, or
apparent personal or professional financial
relationships with proprietary entities that
produce healthcare goods and services.
• Kim Moser – Speakers’ bureaus: Pfizer, Merck,
Glaxo, AstraZeneca
Disclosures
• All planners/managers hereby state that they or their
spouse/life partner do not have any financial
relationships or relationships to products or devices
with any commercial interest related to the content of
this activity of any amount during the past 12 months.
• The following planners/managers have the following to
disclose:
– John J. Dreyzehner, MD, MPH, FACOEM – Ownership
interest: Starfish Health (spouse)
– Robert DuPont – Employment: Bensinger, DuPont &
Associates-Prescription Drug Research Center
Learning Objectives
1. Describe the problem of heroin mixed with
clenbuterol.
2. Explain the protocol developed by the North
Carolina Injury and Prevention Branch to
respond to events that involve overdose.
3. Outline regional partnerships and programs
implemented in Northern Kentucky to respond
to the Rx opioid and heroin epidemic.
4. Provide accurate and appropriate counsel as
part of the treatment team.
Community Responses to the
Prescription Opioid and
Heroin Epidemic
Lessons from Northern
Kentucky
https://www.youtube.com/watch?v=leznM7P2
O0g&feature=player_embedded#t=0
Cincinnati and Northern Kentucky
2014 Overdose Deaths - KY
• The top 7 counties by overdose
• deaths per 100,000 people for 2014 are:
– Floyd County 55.1 per 100,000
– Pike County 50.8 per 100,000
– Campbell County 47.9 per 100,000
– Kenton County 43.3 per 100,000
– Boone County 38.0 per 100,000
– Fayette County 36.6 per 100,000
– McCracken County 30.6 per 100,000
252
447
545
745
1074*
150
350
550
750
950
1150
1350
2011 2012 2013 2014 2015
Ashel Kruetzkamp, MSN, RN— St. Elizabeth Healthcare
*Includes ONLY
Jan-Nov overdoses
Heroin Overdoses
St. Elizabeth Emergency Departments
(Covington, Ft. Thomas, Edgewood, Florence and Grant)
For every woman who dies of a prescription painkiller
overdose, 30 go to the emergency department for painkiller
misuse or abuse
400%
Deaths from prescription painkiller overdoses among women
have increased more than 400% since 1999, compared to
265% among men
48,000
Nearly 48,000 women died of prescription painkiller*
overdoses between 1999 and 2010
(NAS) grew by almost 300% in the US between 2000 and 2009
CDC Vital Signs July 2013
Women and Opiate Addiction
0
50
100
150
200
250
300
Born w/NAS symptoms
Born to moms w/Opiate Hx
Projected 2015 Born w/NAS
NKY 2014 Neonatal
Abstinence Syndrome
2014 2015
EMERGING PUBLIC HEALTH ISSUES
-Northern KY-
Hepatitis C rates:
• 2.7 times that of the rest of the state of Kentucky
• 19.5 times that of the rest of the Nation
IV Drug Use & Disease
INFECTIOUS DISEASES SPREAD BY IV DRUG USE (2014)
Diagnosis Boone
County
Campbell
County
Grant
County
Kenton
County
NKY
*
Acute
hepatitis B
7 7 Fewer
than 5
22 38 (9.4)
Acute
hepatitis C
9 10 Fewer
than 5
22 44 (10.9)
Non-acute
hepatitis B
19 17 Fewer
than 5
40 80 (19.8)
Non-acute
hepatitis C
173 223 66 396 858
(212.7)
HIV cumulative
from 1982, living
and deceased
120 155 31 413 719
Source: NKY Health Department Epidemiology Unit
A CALL TO ACTION
• Parents Advocating Recovery
• Local hospitals
• Law Enforcement
• Judges
• Treatment providers
• Elected Officials
A Community Response
Community Response
Advocacy
Casey’s Law
SB 192
• AN ACT relating to controlled substances and declaring an emergency.
• Be it enacted by the General Assembly of the Commonwealth of Kentucky:
• âSection 1. KRS 72.026 is amended to read as follows:
• (1) [Unless another cause of death is clearly established, ]In cases requiring a post-
mortem examination under KRS 72.025, the coroner or medical examiner shall take a
biological[blood] sample and have it tested for the presence of any controlled
substances which were in the body at the time of death and which at the scene may
have contributed to the cause of death.
• (2) If a coroner or medical examiner determines that a drug overdose is the cause
of death of a person, he or she shall provide notice of the death to:
• (a) The state registrar of vital statistics and the Department of Kentucky State
Police. The notice shall include any information relating to the drug that resulted in
the overdose. The state registrar of vital statistics shall not enter the information on
the deceased person's death certificate unless the information is already on the death
certificate;[ and]
• (b) The licensing board for the individual who prescribed or dispensed the
medication, if known. The notice shall include any information relating to the drug
that resulted in the overdose, including the individual authorized by law to prescribe
or dispense drugs who dispensed or prescribed the drug to the decedent; and
NKY Office of Drug Control Policy
Mission Statement
Provide advisory services to Boone, Campbell
and Kenton County Fiscal Courts on the best
evidence-based treatment and prevention
strategies for reducing Substance Use Disorders
in our community.
NKYODCP: Goals and Initiatives
• Prevention and Education: Community
Engagement
• Treatment: Jail SAPs and Vivitrol Pilot
• Neonatal Abstinence Support Network:
Mothers and Babies
• Legislation: State and Federal
• Law Enforcement: Supply and Harm Reduction
Regional Education and Prevention
Overall reactions to this message are positive. While
a bit startling and unsettling to some, after further
discussion the majority agree that “Inject Hope” offers
the most stopping power, and is a unique and
memorable message. Making it the clear, winner
across all messages- “inject jumps off the page.”
Messaging Reactions | Overall Feedback
Respondents are somewhat polarized in their
reaction to this message. While the majority like the
intent, they feel it is difficult to read and understand.
Others feel it is less powerful than “Inject Hope” but
agree that it is “more hopeful.”
Of the alternatives, participants prefer “Choose”
because it is actionable. They also feel that it is more
gentle than “Inject.” This makes it a good alternative
for placing in family-friendly areas like schools or
grocery stores. This message is liked the most, after
“Inject Hope.”
Majority feel that “this is not the right message,”
and that “Share” is somewhat overused.
Respondents relate this message to cancer research
or breast cancer; of all the messages, it resonates the
least with Heroin and is the least liked overall.
Some respondents also referenced sharing drugs
or needles—not something we want to promote
24% 24% 14% 11%17% 15% 20%
8%
Treatment/
Rehabilitation center
Prevention Early intervention Law enforcement/
Cutting supply
Recovery support
Community Issues
Heroin is a major issue amongst Northern Kentucky residents and they are extremely aware of the impact it has on their community.
“It’s an epidemic.” Almost all respondents agree that drug abuse, specifically, heroin is the most pressing and prevalent issue in their
community.For some this issue is connected other pressing issues in the community like crime, homelessness, poverty and
unemployment.
How the heroin issue is impactingNorthern Kentucky Residents…
Residents are extremely concerned with this issue and feel that there is very little being done to help
prevent or eliminate the problem. As a result, they feel somewhat hopeless due to the lack of solutions
that are currently available. Others are upset or even aggravated by the lack of action related to heroin.
“It’s a crisis that is so
out of control.”
“I think it’s more than just drug
abuse. These people are
medicating something. They
are emotionally hurt… They
have a hole and are trying to
fill it.”
“I can see that there are mechanisms
in place, I just don’t see them
working.”
Personal
Response
Despite high awareness, under half of residents in either Northern Kentucky or Hamilton County have taken any action in response to the growing community
heroin problem. Commonactions among responders include spreading awareness, pointing someone to rehabilitation, and reporting drug activity.
Spreading awareness through
social media or speaking out
Encouraging someone
to enter a
rehabilitation center
Reporting drug activity Offering recovery support
“Kentucky is
considered the
heroin capital of the
US.”
“I have a friend who uses
heroin. What you have to
understand is that he isn’t a
bad guy, he has a great job.
He just fell in with some bad
people. He doesn’t want to get
out.”
“You are not talking
about low-lives. You are
seeing business men
using…”
Thoughts & Feelings Related to Heroin
The most visible messages about heroin
come by way of news media and seem
to leave residents feeling hopeless about
the problem and its severity. Northern
Kentucky residents are particularly
concerned about the rising death rate.
Heroin Message
Opportunity
Treatment, prevention and early intervention are the top rated responses for effectively dealing with Northern Kentucky and Hamilton County’s
heroin problems among residents. Over half also recognize the role of law enforcement and recovery support.
76% 72% 71% 65% 64%69% 72% 71%
55% 54%
Northern Kentucky Residents (n=140)
Community
Response
The heroin problem in Northern Kentucky has high awareness and relevancy among residents.
Hamilton County exhibits a similar, though slightly lower level of problem awareness.
Heroin Awareness & Impact
Nearly half of Northern Kentucky and
Hamilton County residents have been
directly impacted by heroin in some
way.
One in five Northern Kentucky residents
report losing a friend, family member,
or coworker to heroin addiction.
Focus Groups:
• Three 90-minute groups were conducted in late October, 2015, among 18 Northern Kentucky residents
• Objective: deep dive into current attitudes toward heroin addiction in Northern Kentucky,
and test message appeal
Quantitative Online Survey:
• A 15 minute online survey was conducted in early November, 2015 among 140 Northern
Kentucky residents, and 65 Hamilton County residents
• Objective: assess current community awareness and attitudes toward heroin addiction in
Northern Kentucky prior to campaign launch
Research Summary
HELPLINE: No wrong door
First Contact
(Phone, Internet,
Walk-in)
Request for
FAQs
Needs Help
Getting into
Treatment
Crisis
Answers Provided
Referral Linkage
Assessment
by Provider
Engagement & Support
Assessment Placement Follow-Up
Crisis
Management
Kenton Co Detention Center
• 500 beds but typically house 650 inmates
• 83% of state inmates have a history of drug
use and 53% meet criteria for drug
dependence or abuse.*
• Drug treatment program: 70 male beds, 30
female
* KYDOC Division of Substance Abuse Programing
Ongoing Initiatives
• HIDTA Approval for NKY Designation
• Additional treatment: County looking to build
treatment facility
• St. Elizabeth partnership with SUN Behavioral
Health and Betty Ford-Hazelden: 197 beds
• First Step Home treatment model for pregnant
addicted women
Thank you
Community Responses to Heroin
North Carolina’s Heroin/Clenbuterol Experience
Disclosure Statement
• Scott Proescholdbell, MPH, has disclosed no
relevant, real or apparent personal or
professional financial relationships with
proprietary entities that produce health care
goods and services.
• Nidhi Sachdeva, MPH, has disclosed no relevant,
real or apparent personal or professional financial
relationships with proprietary entities that
produce health care goods and services.
Learning Objectives
• Describe the problem of heroin mixed with
clenbuterol
• Explain NC Injury and Violence Prevention
Branch’s (IVPB) communication protocol
developed to respond to events that involve
overdose
Overview
• NC poisoning and overdose epidemic
• Reported clenbuterol cases, Summer 2015
• Development of communication protocol
• Increased collaboration between local health
departments, PH preparedness and response,
and State Bureau of Investigation
• Future/Next Steps
NC’S OVERDOSE EPIDEMIC
36
0.0
5.0
10.0
15.0
20.0
25.0
30.0
35.0
40.0
Deathsper100,000population
Year
Motor Vehicle Traffic (Unintentional)
Drug Poisoning (All Intents)
Firearm (All Intents)
*Per 100,00, age-adjusted to the 2000 U.S. Standard Population
Îą - Transition from ICD-8 to ICD-9
β – Transition from ICD-9 to ICD-10
National Vital Statistics System, http://wonder.cdc.gov, multiple cause dataset
Source: Death files, 1968-2014, CDC WONDER
Analysis by Injury Epidemiology and Surveillance Unit
Death Rates* for Three Selected Causes of Injury, North Carolina, 1968-2014
Îą
Source: N.C. State Center for Health Statistics, Vital Statistics-Deaths, 1999-2014
Analysis by Injury Epidemiology and Surveillance Unit
Medication or drug overdose: X40-X44, X60-X64, Y10-Y14, X85
Medication or Drug Overdose Deaths by Intent
North Carolina Residents, 1999-2014
1,306
1,064
203
38
0
200
400
600
800
1,000
1,200
1,400
Numberofdeaths
All intents
Unintentional
Self-inflicted
Undetermined
Assault
Source: N.C. State Center for Health Statistics, Vital Statistics-Deaths, 1999-2014
Analysis by Injury Epidemiology and Surveillance Unit
Substances Contributing to Medication or Drug Overdose Deaths
North Carolina Residents, 1999-2014
684
202
246
0
100
200
300
400
500
600
700
800
900
Numberofdeaths
Prescription Opioid
Cocaine
Heroin
NC Heroin Deaths: 2008-2015*
Source: N.C. State Center for Health Statistics, Vital Statistics-Deaths, 2008- 2015*
*2015 data are provisional and likely increase as cases are finalized
Analysis by Injury Epidemiology and Surveillance Unit
554% increase from
2010 to 2014
63
75
37
76
147
179
246
174
0
50
100
150
200
250
300
2008 2009 2010 2011 2012 2013 2014 2015*
Heroin Hosp. and ED Overdoses: 2008-2014
Source: N.C. State Center for Health Statistics, Vital Statistics-Hospital Discharge 2008- 2013
NC DETECT- Statewide ED Visit data, 2008-2014
Analysis by Injury Epidemiology and Surveillance Unit
213
252
213
311
474
643
1,127
76 75 58
101 122
195
0
200
400
600
800
1000
1200
2008 2009 2010 2011 2012 2013 2014
ED Hosp
From 2010 to 2014
a 429% increase
for ED visits
Recent Publications on Heroin Increases
Adulterated Heroin Increases
Mmwr-RI-6324
Heroin/Clenbuterol Cases
Virginia March 2015
• 15 cases reported
• Collaboration between state health, poison,
health facility and law enforcement
• Exchange of information and lessons learned
• Recent presentations and pending publication
NC HEROIN/CLENBUTEROL
Clenbuterol
• A Beta-2-agonist, veterinary medication (horses)
• Side effects
– Tachycardia, palpitations, hypokalemia, hypotension,
elevated lactate, metabolic acidosis
• Drug of abuse among athletes
• Inexpensive, readily available (websites)
Heroin/Clenbuterol
• Reports from the field mentioned both dealers
diluting and dealers adding for euphoric effect
• Recently, IVPB connected with community users
– Most mentioned that it was intentional and meant
to mimic a ‘speedball’ (cocaine/heroin)
• Users mention ‘blue heroin’ in reports
Reports from Users
Person 1
"I have been talking about this with a group of
people. Scramble is a mix they have in the
Baltimore area – very different from this blue
(seems to be synthetic) dope. I have a person
working on finding out about this.....we think its a
product of the deep web, more info as I get it."
Reports from Users
Person 2
I actually talked to someone…about this and I was
saying that I didn't think it was actual dope (the
blue stuff). It just wouldn't make sense...I'd think
that'd stop people from buying it. I know that I
wouldn't buy dope that was blue. Research chem
makes sense. I thought research chem makers had
had a hard time creating an opioid version over
the years, but it does make sense that they'd
eventually get there.
Reports from Users
Person 3
In Baltimore there are two types of heroin: scramble and
raw. Raw is hard rocks and is usually sold in tiny glass
vials or by weight. Scramble is usually packed into gel
caps (looks like a gel cap Advil, for example).
I've also never seen blue scramble. It's usually light, light
brown or white.
I'd think that what the guy is talking about is a local issue
and not a larger thing.
Reports from Users
Person 3
Scramble is usually cut with all kinds of things. I
hated it but some people love it because the rush is
different - I always thought the rush sucked. I've
never seen scramble down here or even in DC, but
that doesn't mean it isn't. It wouldn't surprise me
if people get sick off of it. It's seriously cut with
whatever is around that may or may not have
some sort of effect on the rush.
Reports from Users
Person 4
Yeah, a bunch of my friends have started doing it
recently. It feels like fentanyl but just keeps
getting stronger and stronger. I don’t know
what the f**k it is but its heavy man... Like
people are overdosing left and right. :/ I'll look
into it, one of the big guys here in Wilmington is
mainly selling it. I'll talk to her. Let you know
more when I do!
7/7/2015, 6pm
Email from Carolina
Poison Control-report
of ‘possible’
heroin/clenbuterol
7/8/2015, 7am
IVPB sends soft
‘alert’ email sent to
overdose community
and Epi Section.
MMRW/Hoffman
7/9/2015, 3pm
What is IVPB
‘investigation
process’? (3-5
possible cases)
7/9/2015, 5pm
Senior leadership
looped in and asked
for IVPB response
7/9/2015
Reporting hospital
developing case
definition/survey
(additional cases
reported)
7/9/2015
Waiting for lab
confirmation, most
leaving against
medical advice (AMA)
7/9/2015, 6pm
NC should send out
media alert (based on
2-7 cases)
7/9/2015, 6pm
NC should send out
media alert (based on
2-7 cases)
7/10/2015, 9am
State Epi asking for
update on
communication/
media alert
7/10/2015, 4pm
Carolina Poison
Center sends out
media alert (9 cases)
7/11/2015
Handful of media
outlets pick up alert
7/15/2015
10 cases reported to
date, several
pending/some
outlying counties but
connection with
reporting county
7/17-7/19/2015
New potential cases
reported
7/19/2015
CDC Epi-X alert
(18-cases)
7/20/2015
NC HAN/Letter to
providers (18 cases)
NC Heroin/Clenbuterol Timeline, 2015
NC Heroin/Clenbuterol Cases
NC Health Alert Network (NC HAN)
NC Provider Letter/Alert
CDC Epi-X Alert
NC Heroin/Clenbuterol Cases by Date, 2015
0
1
2
3
4
DEVELOPMENT OF
COMMUNICATIONS PROTOCOL
Development of Injury Warning
• IVPB had new role in response
• IVPB ‘thin’ bench and lack of response experience
– Must coordinate with others
• Several debriefings with key partners
• Creation of Early Injury Warning system
• IVPB staff added to NC HAN, Situation Report lists
• Asked to expand our role
NC Injury Warning
Communication Protocol
1. Activation
2. Investigation/
Monitoring
3. Communication
Small Test, January-February 2016
• Carolinas Poison Control emailed 1/22/16
with reported ‘possible’ new case in central
NC (same facility as July)
• Within 24 hours
– All informal alerts were sent
– sit.report sent to senior leadership, affected areas
• Monitoring: No additional cases reported
NC Situation Report (Sit. Report)
INCREASING COLLABORATION
BETWEEN KEY STAKEHOLDERS
North Carolina Injury and Violence Prevention Branch, Partners
Poisoning Death Study
Comprehensive Community Approach
Chronic Pain Initiative
Opioid Death Task Force
Policy and Practice
Research
North Carolina
Prevention and
Harm Reduction
Drug Take Back
Prescription
Drug
Substance
Abuse
SAC Poisoning/Overdose
Team Communication, Policy,
and Advocacy
Enforcement
SBI and Medical &
Pharm Board
DPH, DMA, DMH/DD/SAS,
ORH
Carolinas Poison Center
Monitoring
Program
Partners
• NC Public Health Preparedness and Response
• State Bureau of Investigation (SBI) Information
Sharing and Analysis Center (ISAAC)
• DPH Epi Section
– Communicable diseases, food borne diseases, etc.
• Clinical providers in ED (toxicologists)
• Expanded relationship with Carolinas Poison
Center
TRACKING & MONITORING
NC DETECT / ED Data Mandate
GS § 130A-480
(a) For the purpose of ensuring the protection of the public health, the State Health Director
shall develop a syndromic surveillance program for hospital emergency departments in
order to detect and investigate public health threats that may result from
(i) a terrorist incident using nuclear, biological, or chemical agents or
(ii) an epidemic or infectious, communicable, or other disease.
The State Health Director shall maintain the confidentiality of the data reported pursuant to
this section and shall ensure that adequate measures are taken to provide system security
for all data and information. The State Health Director may share data with local health
departments for public health purposes, and the local health departments are bound by
the confidentiality provisions of this section. The State Health Director shall not allow
information that it receives pursuant to this section to be used for commercial purposes and
shall not release data except as authorized by other provisions of law.
*Effective 1/1/2005
*Law modified in 2007 to allow sharing of reported hospital ED data with CDC
NC DETECT Overdose Visits
Source: North Carolina NC DETECT
Access to NC DETECT
• NC DETECT web application access for
– Local Health Departments
– Data Providers (Hospitals, EMS, Poison Center)
• Authorized users are able to view data from
– Emergency Departments
– Carolinas Poison Center
– Pre-hospital Medical Information System (PreMIS)
• Training webinars provided by DPH, NC DETECT
• Datasets shared with researchers after DUA and
IRB approval
Hot Topics Dashboard
Click on a point to
access line listing
Reach Back Mode
• When authorized, NC DPH can review medical records
• Reach back mode been utilized in 2 overdose situations
– TTP (Opana ER, IDU): 12 hospitalizations in TN
– Heroin/Clenbuterol
• Use of NC DETECT to find general heroin cases can then
be retrospectively reviewed to see if there are other
indications of adulteration (heart palpitations, X, Y, Z)
• OR during outbreak to potentially find additional cases
meeting definition
EVALUATION
Evaluation of Protocol
• What triggers an activation?
• Who initiates first alert to activate the
protocol?
• Who receives the notice?
– Most effective communication channel for each
target population?
– How to best reach most at risk in shortest time?
• How much time does it take to go from first
alert to a communication notice?
Evaluation of Protocol
• Balancing potential public panic vs.
responsibility to alert of injury dangers
• When to consider “case closed”?
• Expanding NC State Injury Prevention Program
– Always prevention, increasingly reactive
NC’S NEXT STEPS…
CDC Prescription Drug Overdose (PDO)
Prevention for States (PfS)
For more information…
Scott Proescholdbell, MPH
scott.proescholdbell@dhhs.nc.gov
Nidhi Sachdeva, MPH
nidhi.sachdeva@dhhs.nc.gov
Injury and Violence Prevention Branch
NC Division of Public Health
www.injuryfreenc.ncdhhs.gov | www.injuryfreenc.org
Community Responses to Heroin:
North Carolina and Northern Kentucky
Presenters:
• Kim Moser, Director, Northern Kentucky Office of Drug Control
• Scott Proescholdbell, MPH, Epidemiologist, Injury and Violence
Prevention Branch, North Carolina Department of Health and Human
Services
• Nidhi Sachdeva, MPH, Injury Prevention Consultant, Division of Public
Health, North Carolina Department of Health and Human Services
Heroin Track
Moderator: Kelly J. Clark, MD, MBA, FASAM, DFAPA, President-elect,
American Society of Addiction Medicine, and Member, Rx and Heroin
Summit National Advisory Board

More Related Content

What's hot

Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeonRx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeonOPUNITE
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerOPUNITE
 
Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynoteOPUNITE
 
Rx16 pharma tues_330_1_painter_2lev_3green
Rx16 pharma tues_330_1_painter_2lev_3greenRx16 pharma tues_330_1_painter_2lev_3green
Rx16 pharma tues_330_1_painter_2lev_3greenOPUNITE
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleOPUNITE
 
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earleRx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earleOPUNITE
 
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebran
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebranRevised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebran
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebranOPUNITE
 
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylorRx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylorOPUNITE
 
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrownRx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrownOPUNITE
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_finalOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2wallerRx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2wallerOPUNITE
 
Web only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haasWeb only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haasOPUNITE
 
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyWeb only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyOPUNITE
 
Rx16 vs nadcp_tues_800_1_walton
Rx16 vs nadcp_tues_800_1_waltonRx16 vs nadcp_tues_800_1_walton
Rx16 vs nadcp_tues_800_1_waltonOPUNITE
 
Rx16 treat tues_200_1_jarvis_2fiscella_3balonick
Rx16 treat tues_200_1_jarvis_2fiscella_3balonickRx16 treat tues_200_1_jarvis_2fiscella_3balonick
Rx16 treat tues_200_1_jarvis_2fiscella_3balonickOPUNITE
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanOPUNITE
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenOPUNITE
 
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiroWeb only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiroOPUNITE
 
Rx16 workshop 200_group_ppt
Rx16 workshop 200_group_pptRx16 workshop 200_group_ppt
Rx16 workshop 200_group_pptOPUNITE
 

What's hot (20)

Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeonRx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
 
Rx16 pharma tues_330_1_painter_2lev_3green
Rx16 pharma tues_330_1_painter_2lev_3greenRx16 pharma tues_330_1_painter_2lev_3green
Rx16 pharma tues_330_1_painter_2lev_3green
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
 
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earleRx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
 
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebran
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebranRevised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebran
Revised order rx16 pdmp wed_1115_1_eadie_2reilly_3hallvik_4hildebran
 
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylorRx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
 
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrownRx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
Rx16 federal tues_1115_1_fretwell_2gabbert-wilkebrown
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2wallerRx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2waller
 
Web only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haasWeb only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haas
 
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyWeb only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
 
Rx16 vs nadcp_tues_800_1_walton
Rx16 vs nadcp_tues_800_1_waltonRx16 vs nadcp_tues_800_1_walton
Rx16 vs nadcp_tues_800_1_walton
 
Rx16 treat tues_200_1_jarvis_2fiscella_3balonick
Rx16 treat tues_200_1_jarvis_2fiscella_3balonickRx16 treat tues_200_1_jarvis_2fiscella_3balonick
Rx16 treat tues_200_1_jarvis_2fiscella_3balonick
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiroWeb only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
 
Rx16 workshop 200_group_ppt
Rx16 workshop 200_group_pptRx16 workshop 200_group_ppt
Rx16 workshop 200_group_ppt
 

Similar to Rx16 heroin tues_330_1_moser_2proescholdbell-sachdeva

Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahana
Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahanaRx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahana
Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahanaOPUNITE
 
Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahana
Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahanaRx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahana
Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahanaOPUNITE
 
Rx15 clinical wed_300_1_baier_2desrosiers_3hawkinberry-paxton
Rx15 clinical wed_300_1_baier_2desrosiers_3hawkinberry-paxtonRx15 clinical wed_300_1_baier_2desrosiers_3hawkinberry-paxton
Rx15 clinical wed_300_1_baier_2desrosiers_3hawkinberry-paxtonOPUNITE
 
Rx15 ea wed_300_1_perry-martin_2wethington
Rx15 ea wed_300_1_perry-martin_2wethingtonRx15 ea wed_300_1_perry-martin_2wethington
Rx15 ea wed_300_1_perry-martin_2wethingtonOPUNITE
 
9-20-2016OklahomaCityPresentationMBL
9-20-2016OklahomaCityPresentationMBL9-20-2016OklahomaCityPresentationMBL
9-20-2016OklahomaCityPresentationMBLMary Beth Levin
 
Toronto_City_Hall_Presentation_August_4th,_2015[1]
Toronto_City_Hall_Presentation_August_4th,_2015[1]Toronto_City_Hall_Presentation_August_4th,_2015[1]
Toronto_City_Hall_Presentation_August_4th,_2015[1]Kevin Hall
 
The Domino Effect
The Domino EffectThe Domino Effect
The Domino EffectMark Branlund
 
2011 9-22_LeonEvans_presentation_Lilly-Community_Conversationsv3_final
2011 9-22_LeonEvans_presentation_Lilly-Community_Conversationsv3_final2011 9-22_LeonEvans_presentation_Lilly-Community_Conversationsv3_final
2011 9-22_LeonEvans_presentation_Lilly-Community_Conversationsv3_finalGilbert Gonzales
 
Integration of Behavioral and Primary Care
Integration of Behavioral and Primary CareIntegration of Behavioral and Primary Care
Integration of Behavioral and Primary CareMatthew Dunning
 
Na Co Florida Lee County Estero V4
Na Co Florida Lee County Estero V4Na Co Florida Lee County Estero V4
Na Co Florida Lee County Estero V4Gilbert Gonzales
 
San Joaquin County CaliforniaPresented by Virginia Borrell .docx
San Joaquin County CaliforniaPresented by   Virginia Borrell .docxSan Joaquin County CaliforniaPresented by   Virginia Borrell .docx
San Joaquin County CaliforniaPresented by Virginia Borrell .docxanhlodge
 
Human rights watch scpg presentation 11.10.11
Human rights watch scpg presentation 11.10.11Human rights watch scpg presentation 11.10.11
Human rights watch scpg presentation 11.10.11mellarocomolter
 
Rx15 vision tues_800_uk
Rx15 vision tues_800_ukRx15 vision tues_800_uk
Rx15 vision tues_800_ukOPUNITE
 
Webinar: Successful COVID-19 Messaging in Rural Communities
Webinar: Successful COVID-19 Messaging in Rural CommunitiesWebinar: Successful COVID-19 Messaging in Rural Communities
Webinar: Successful COVID-19 Messaging in Rural Communitiesde Beaumont Foundation
 
Ea 1 bullard cawhtorne_ taylorpowell_heeke
Ea 1 bullard cawhtorne_ taylorpowell_heekeEa 1 bullard cawhtorne_ taylorpowell_heeke
Ea 1 bullard cawhtorne_ taylorpowell_heekeOPUNITE
 
Lilly Bloomington Illinois Dec 2009
Lilly Bloomington Illinois Dec 2009Lilly Bloomington Illinois Dec 2009
Lilly Bloomington Illinois Dec 2009Gilbert Gonzales
 
Ea 6 fingerson gay
Ea 6 fingerson gayEa 6 fingerson gay
Ea 6 fingerson gayOPUNITE
 
Civics Presentation - Salvador Galvan.pptx
Civics Presentation - Salvador Galvan.pptxCivics Presentation - Salvador Galvan.pptx
Civics Presentation - Salvador Galvan.pptxsgalvan1
 
Ea 5 peterson perry
Ea 5 peterson perryEa 5 peterson perry
Ea 5 peterson perryOPUNITE
 
Public Health in the Correctional Setting: Challenges & Opportunities
Public Health in the Correctional Setting: Challenges & OpportunitiesPublic Health in the Correctional Setting: Challenges & Opportunities
Public Health in the Correctional Setting: Challenges & OpportunitiesAmanda Edgar
 

Similar to Rx16 heroin tues_330_1_moser_2proescholdbell-sachdeva (20)

Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahana
Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahanaRx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahana
Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahana
 
Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahana
Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahanaRx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahana
Rx15 ea wed_1230_1_frattaroli_2kolodny_3chan_4cahana
 
Rx15 clinical wed_300_1_baier_2desrosiers_3hawkinberry-paxton
Rx15 clinical wed_300_1_baier_2desrosiers_3hawkinberry-paxtonRx15 clinical wed_300_1_baier_2desrosiers_3hawkinberry-paxton
Rx15 clinical wed_300_1_baier_2desrosiers_3hawkinberry-paxton
 
Rx15 ea wed_300_1_perry-martin_2wethington
Rx15 ea wed_300_1_perry-martin_2wethingtonRx15 ea wed_300_1_perry-martin_2wethington
Rx15 ea wed_300_1_perry-martin_2wethington
 
9-20-2016OklahomaCityPresentationMBL
9-20-2016OklahomaCityPresentationMBL9-20-2016OklahomaCityPresentationMBL
9-20-2016OklahomaCityPresentationMBL
 
Toronto_City_Hall_Presentation_August_4th,_2015[1]
Toronto_City_Hall_Presentation_August_4th,_2015[1]Toronto_City_Hall_Presentation_August_4th,_2015[1]
Toronto_City_Hall_Presentation_August_4th,_2015[1]
 
The Domino Effect
The Domino EffectThe Domino Effect
The Domino Effect
 
2011 9-22_LeonEvans_presentation_Lilly-Community_Conversationsv3_final
2011 9-22_LeonEvans_presentation_Lilly-Community_Conversationsv3_final2011 9-22_LeonEvans_presentation_Lilly-Community_Conversationsv3_final
2011 9-22_LeonEvans_presentation_Lilly-Community_Conversationsv3_final
 
Integration of Behavioral and Primary Care
Integration of Behavioral and Primary CareIntegration of Behavioral and Primary Care
Integration of Behavioral and Primary Care
 
Na Co Florida Lee County Estero V4
Na Co Florida Lee County Estero V4Na Co Florida Lee County Estero V4
Na Co Florida Lee County Estero V4
 
San Joaquin County CaliforniaPresented by Virginia Borrell .docx
San Joaquin County CaliforniaPresented by   Virginia Borrell .docxSan Joaquin County CaliforniaPresented by   Virginia Borrell .docx
San Joaquin County CaliforniaPresented by Virginia Borrell .docx
 
Human rights watch scpg presentation 11.10.11
Human rights watch scpg presentation 11.10.11Human rights watch scpg presentation 11.10.11
Human rights watch scpg presentation 11.10.11
 
Rx15 vision tues_800_uk
Rx15 vision tues_800_ukRx15 vision tues_800_uk
Rx15 vision tues_800_uk
 
Webinar: Successful COVID-19 Messaging in Rural Communities
Webinar: Successful COVID-19 Messaging in Rural CommunitiesWebinar: Successful COVID-19 Messaging in Rural Communities
Webinar: Successful COVID-19 Messaging in Rural Communities
 
Ea 1 bullard cawhtorne_ taylorpowell_heeke
Ea 1 bullard cawhtorne_ taylorpowell_heekeEa 1 bullard cawhtorne_ taylorpowell_heeke
Ea 1 bullard cawhtorne_ taylorpowell_heeke
 
Lilly Bloomington Illinois Dec 2009
Lilly Bloomington Illinois Dec 2009Lilly Bloomington Illinois Dec 2009
Lilly Bloomington Illinois Dec 2009
 
Ea 6 fingerson gay
Ea 6 fingerson gayEa 6 fingerson gay
Ea 6 fingerson gay
 
Civics Presentation - Salvador Galvan.pptx
Civics Presentation - Salvador Galvan.pptxCivics Presentation - Salvador Galvan.pptx
Civics Presentation - Salvador Galvan.pptx
 
Ea 5 peterson perry
Ea 5 peterson perryEa 5 peterson perry
Ea 5 peterson perry
 
Public Health in the Correctional Setting: Challenges & Opportunities
Public Health in the Correctional Setting: Challenges & OpportunitiesPublic Health in the Correctional Setting: Challenges & Opportunities
Public Health in the Correctional Setting: Challenges & Opportunities
 

More from OPUNITE

Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynoteOPUNITE
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynoteOPUNITE
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingOPUNITE
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyOPUNITE
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessOPUNITE
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattOPUNITE
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerOPUNITE
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_groupOPUNITE
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldOPUNITE
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioOPUNITE
 
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerRx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerOPUNITE
 
Rx16 federal visionsession_200
Rx16 federal visionsession_200Rx16 federal visionsession_200
Rx16 federal visionsession_200OPUNITE
 
Rx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2greenRx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2greenOPUNITE
 
Rx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorinRx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorinOPUNITE
 

More from OPUNITE (16)

Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
 
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerRx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
 
Rx16 federal visionsession_200
Rx16 federal visionsession_200Rx16 federal visionsession_200
Rx16 federal visionsession_200
 
Rx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2greenRx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2green
 
Rx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorinRx16 federal wed_1230_1_kelly_2bohn-killorin
Rx16 federal wed_1230_1_kelly_2bohn-killorin
 

Recently uploaded

Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort ServiceCollege Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort ServiceNehru place Escorts
 
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiCall Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiNehru place Escorts
 
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safenarwatsonia7
 
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service JaipurHigh Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipurparulsinha
 
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...narwatsonia7
 
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service MumbaiLow Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbaisonalikaur4
 
Call Girls Budhwar Peth 7001305949 All Area Service COD available Any Time
Call Girls Budhwar Peth 7001305949 All Area Service COD available Any TimeCall Girls Budhwar Peth 7001305949 All Area Service COD available Any Time
Call Girls Budhwar Peth 7001305949 All Area Service COD available Any Timevijaych2041
 
Call Girl Lucknow Mallika 7001305949 Independent Escort Service Lucknow
Call Girl Lucknow Mallika 7001305949 Independent Escort Service LucknowCall Girl Lucknow Mallika 7001305949 Independent Escort Service Lucknow
Call Girl Lucknow Mallika 7001305949 Independent Escort Service Lucknownarwatsonia7
 
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...narwatsonia7
 
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...narwatsonia7
 
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...Miss joya
 
Aspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliAspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliRewAs ALI
 
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service MumbaiVIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbaisonalikaur4
 
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...narwatsonia7
 
Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...
Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...
Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...narwatsonia7
 
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Miss joya
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableNehru place Escorts
 

Recently uploaded (20)

Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Available
 
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort ServiceCollege Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
 
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiCall Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
 
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
 
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service JaipurHigh Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
 
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
 
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service MumbaiLow Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
 
Call Girls Budhwar Peth 7001305949 All Area Service COD available Any Time
Call Girls Budhwar Peth 7001305949 All Area Service COD available Any TimeCall Girls Budhwar Peth 7001305949 All Area Service COD available Any Time
Call Girls Budhwar Peth 7001305949 All Area Service COD available Any Time
 
Call Girl Lucknow Mallika 7001305949 Independent Escort Service Lucknow
Call Girl Lucknow Mallika 7001305949 Independent Escort Service LucknowCall Girl Lucknow Mallika 7001305949 Independent Escort Service Lucknow
Call Girl Lucknow Mallika 7001305949 Independent Escort Service Lucknow
 
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
 
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
 
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
 
Aspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliAspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas Ali
 
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service MumbaiVIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
 
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
 
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
 
Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...
Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...
Housewife Call Girls Bangalore - Call 7001305949 Rs-3500 with A/C Room Cash o...
 
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Servicesauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
 
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
 

Rx16 heroin tues_330_1_moser_2proescholdbell-sachdeva

  • 1. Community Responses to Heroin: North Carolina and Northern Kentucky Presenters: • Kim Moser, Director, Northern Kentucky Office of Drug Control • Scott Proescholdbell, MPH, Epidemiologist, Injury and Violence Prevention Branch, North Carolina Department of Health and Human Services • Nidhi Sachdeva, MPH, Injury Prevention Consultant, Division of Public Health, North Carolina Department of Health and Human Services Heroin Track Moderator: Kelly J. Clark, MD, MBA, FASAM, DFAPA, President-elect, American Society of Addiction Medicine, and Member, Rx and Heroin Summit National Advisory Board
  • 2. Disclosures • Scott Proescholdbell, MPH; Nidhi Sachdeva, MPH; and Kelly J. Clark, MD, MBA, FASAM, DFAPA, have disclosed no relevant, real, or apparent personal or professional financial relationships with proprietary entities that produce healthcare goods and services. • Kim Moser – Speakers’ bureaus: Pfizer, Merck, Glaxo, AstraZeneca
  • 3. Disclosures • All planners/managers hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. • The following planners/managers have the following to disclose: – John J. Dreyzehner, MD, MPH, FACOEM – Ownership interest: Starfish Health (spouse) – Robert DuPont – Employment: Bensinger, DuPont & Associates-Prescription Drug Research Center
  • 4. Learning Objectives 1. Describe the problem of heroin mixed with clenbuterol. 2. Explain the protocol developed by the North Carolina Injury and Prevention Branch to respond to events that involve overdose. 3. Outline regional partnerships and programs implemented in Northern Kentucky to respond to the Rx opioid and heroin epidemic. 4. Provide accurate and appropriate counsel as part of the treatment team.
  • 5. Community Responses to the Prescription Opioid and Heroin Epidemic Lessons from Northern Kentucky
  • 8.
  • 9. 2014 Overdose Deaths - KY • The top 7 counties by overdose • deaths per 100,000 people for 2014 are: – Floyd County 55.1 per 100,000 – Pike County 50.8 per 100,000 – Campbell County 47.9 per 100,000 – Kenton County 43.3 per 100,000 – Boone County 38.0 per 100,000 – Fayette County 36.6 per 100,000 – McCracken County 30.6 per 100,000
  • 10. 252 447 545 745 1074* 150 350 550 750 950 1150 1350 2011 2012 2013 2014 2015 Ashel Kruetzkamp, MSN, RN— St. Elizabeth Healthcare *Includes ONLY Jan-Nov overdoses Heroin Overdoses St. Elizabeth Emergency Departments (Covington, Ft. Thomas, Edgewood, Florence and Grant)
  • 11. For every woman who dies of a prescription painkiller overdose, 30 go to the emergency department for painkiller misuse or abuse 400% Deaths from prescription painkiller overdoses among women have increased more than 400% since 1999, compared to 265% among men 48,000 Nearly 48,000 women died of prescription painkiller* overdoses between 1999 and 2010 (NAS) grew by almost 300% in the US between 2000 and 2009 CDC Vital Signs July 2013 Women and Opiate Addiction
  • 12. 0 50 100 150 200 250 300 Born w/NAS symptoms Born to moms w/Opiate Hx Projected 2015 Born w/NAS NKY 2014 Neonatal Abstinence Syndrome 2014 2015
  • 13. EMERGING PUBLIC HEALTH ISSUES -Northern KY- Hepatitis C rates: • 2.7 times that of the rest of the state of Kentucky • 19.5 times that of the rest of the Nation
  • 14. IV Drug Use & Disease INFECTIOUS DISEASES SPREAD BY IV DRUG USE (2014) Diagnosis Boone County Campbell County Grant County Kenton County NKY * Acute hepatitis B 7 7 Fewer than 5 22 38 (9.4) Acute hepatitis C 9 10 Fewer than 5 22 44 (10.9) Non-acute hepatitis B 19 17 Fewer than 5 40 80 (19.8) Non-acute hepatitis C 173 223 66 396 858 (212.7) HIV cumulative from 1982, living and deceased 120 155 31 413 719 Source: NKY Health Department Epidemiology Unit
  • 15. A CALL TO ACTION • Parents Advocating Recovery • Local hospitals • Law Enforcement • Judges • Treatment providers • Elected Officials
  • 18.
  • 21. SB 192 • AN ACT relating to controlled substances and declaring an emergency. • Be it enacted by the General Assembly of the Commonwealth of Kentucky: • âSection 1. KRS 72.026 is amended to read as follows: • (1) [Unless another cause of death is clearly established, ]In cases requiring a post- mortem examination under KRS 72.025, the coroner or medical examiner shall take a biological[blood] sample and have it tested for the presence of any controlled substances which were in the body at the time of death and which at the scene may have contributed to the cause of death. • (2) If a coroner or medical examiner determines that a drug overdose is the cause of death of a person, he or she shall provide notice of the death to: • (a) The state registrar of vital statistics and the Department of Kentucky State Police. The notice shall include any information relating to the drug that resulted in the overdose. The state registrar of vital statistics shall not enter the information on the deceased person's death certificate unless the information is already on the death certificate;[ and] • (b) The licensing board for the individual who prescribed or dispensed the medication, if known. The notice shall include any information relating to the drug that resulted in the overdose, including the individual authorized by law to prescribe or dispense drugs who dispensed or prescribed the drug to the decedent; and
  • 22. NKY Office of Drug Control Policy Mission Statement Provide advisory services to Boone, Campbell and Kenton County Fiscal Courts on the best evidence-based treatment and prevention strategies for reducing Substance Use Disorders in our community.
  • 23. NKYODCP: Goals and Initiatives • Prevention and Education: Community Engagement • Treatment: Jail SAPs and Vivitrol Pilot • Neonatal Abstinence Support Network: Mothers and Babies • Legislation: State and Federal • Law Enforcement: Supply and Harm Reduction
  • 25. Overall reactions to this message are positive. While a bit startling and unsettling to some, after further discussion the majority agree that “Inject Hope” offers the most stopping power, and is a unique and memorable message. Making it the clear, winner across all messages- “inject jumps off the page.” Messaging Reactions | Overall Feedback Respondents are somewhat polarized in their reaction to this message. While the majority like the intent, they feel it is difficult to read and understand. Others feel it is less powerful than “Inject Hope” but agree that it is “more hopeful.” Of the alternatives, participants prefer “Choose” because it is actionable. They also feel that it is more gentle than “Inject.” This makes it a good alternative for placing in family-friendly areas like schools or grocery stores. This message is liked the most, after “Inject Hope.” Majority feel that “this is not the right message,” and that “Share” is somewhat overused. Respondents relate this message to cancer research or breast cancer; of all the messages, it resonates the least with Heroin and is the least liked overall. Some respondents also referenced sharing drugs or needles—not something we want to promote
  • 26. 24% 24% 14% 11%17% 15% 20% 8% Treatment/ Rehabilitation center Prevention Early intervention Law enforcement/ Cutting supply Recovery support Community Issues Heroin is a major issue amongst Northern Kentucky residents and they are extremely aware of the impact it has on their community. “It’s an epidemic.” Almost all respondents agree that drug abuse, specifically, heroin is the most pressing and prevalent issue in their community.For some this issue is connected other pressing issues in the community like crime, homelessness, poverty and unemployment. How the heroin issue is impactingNorthern Kentucky Residents… Residents are extremely concerned with this issue and feel that there is very little being done to help prevent or eliminate the problem. As a result, they feel somewhat hopeless due to the lack of solutions that are currently available. Others are upset or even aggravated by the lack of action related to heroin. “It’s a crisis that is so out of control.” “I think it’s more than just drug abuse. These people are medicating something. They are emotionally hurt… They have a hole and are trying to fill it.” “I can see that there are mechanisms in place, I just don’t see them working.” Personal Response Despite high awareness, under half of residents in either Northern Kentucky or Hamilton County have taken any action in response to the growing community heroin problem. Commonactions among responders include spreading awareness, pointing someone to rehabilitation, and reporting drug activity. Spreading awareness through social media or speaking out Encouraging someone to enter a rehabilitation center Reporting drug activity Offering recovery support “Kentucky is considered the heroin capital of the US.” “I have a friend who uses heroin. What you have to understand is that he isn’t a bad guy, he has a great job. He just fell in with some bad people. He doesn’t want to get out.” “You are not talking about low-lives. You are seeing business men using…” Thoughts & Feelings Related to Heroin The most visible messages about heroin come by way of news media and seem to leave residents feeling hopeless about the problem and its severity. Northern Kentucky residents are particularly concerned about the rising death rate. Heroin Message Opportunity Treatment, prevention and early intervention are the top rated responses for effectively dealing with Northern Kentucky and Hamilton County’s heroin problems among residents. Over half also recognize the role of law enforcement and recovery support. 76% 72% 71% 65% 64%69% 72% 71% 55% 54% Northern Kentucky Residents (n=140) Community Response The heroin problem in Northern Kentucky has high awareness and relevancy among residents. Hamilton County exhibits a similar, though slightly lower level of problem awareness. Heroin Awareness & Impact Nearly half of Northern Kentucky and Hamilton County residents have been directly impacted by heroin in some way. One in five Northern Kentucky residents report losing a friend, family member, or coworker to heroin addiction. Focus Groups: • Three 90-minute groups were conducted in late October, 2015, among 18 Northern Kentucky residents • Objective: deep dive into current attitudes toward heroin addiction in Northern Kentucky, and test message appeal Quantitative Online Survey: • A 15 minute online survey was conducted in early November, 2015 among 140 Northern Kentucky residents, and 65 Hamilton County residents • Objective: assess current community awareness and attitudes toward heroin addiction in Northern Kentucky prior to campaign launch Research Summary
  • 27. HELPLINE: No wrong door First Contact (Phone, Internet, Walk-in) Request for FAQs Needs Help Getting into Treatment Crisis Answers Provided Referral Linkage Assessment by Provider Engagement & Support Assessment Placement Follow-Up Crisis Management
  • 28. Kenton Co Detention Center • 500 beds but typically house 650 inmates • 83% of state inmates have a history of drug use and 53% meet criteria for drug dependence or abuse.* • Drug treatment program: 70 male beds, 30 female * KYDOC Division of Substance Abuse Programing
  • 29. Ongoing Initiatives • HIDTA Approval for NKY Designation • Additional treatment: County looking to build treatment facility • St. Elizabeth partnership with SUN Behavioral Health and Betty Ford-Hazelden: 197 beds • First Step Home treatment model for pregnant addicted women
  • 31. Community Responses to Heroin North Carolina’s Heroin/Clenbuterol Experience
  • 32. Disclosure Statement • Scott Proescholdbell, MPH, has disclosed no relevant, real or apparent personal or professional financial relationships with proprietary entities that produce health care goods and services. • Nidhi Sachdeva, MPH, has disclosed no relevant, real or apparent personal or professional financial relationships with proprietary entities that produce health care goods and services.
  • 33. Learning Objectives • Describe the problem of heroin mixed with clenbuterol • Explain NC Injury and Violence Prevention Branch’s (IVPB) communication protocol developed to respond to events that involve overdose
  • 34. Overview • NC poisoning and overdose epidemic • Reported clenbuterol cases, Summer 2015 • Development of communication protocol • Increased collaboration between local health departments, PH preparedness and response, and State Bureau of Investigation • Future/Next Steps
  • 36. 36 0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0 Deathsper100,000population Year Motor Vehicle Traffic (Unintentional) Drug Poisoning (All Intents) Firearm (All Intents) *Per 100,00, age-adjusted to the 2000 U.S. Standard Population Îą - Transition from ICD-8 to ICD-9 β – Transition from ICD-9 to ICD-10 National Vital Statistics System, http://wonder.cdc.gov, multiple cause dataset Source: Death files, 1968-2014, CDC WONDER Analysis by Injury Epidemiology and Surveillance Unit Death Rates* for Three Selected Causes of Injury, North Carolina, 1968-2014 Îą
  • 37. Source: N.C. State Center for Health Statistics, Vital Statistics-Deaths, 1999-2014 Analysis by Injury Epidemiology and Surveillance Unit Medication or drug overdose: X40-X44, X60-X64, Y10-Y14, X85 Medication or Drug Overdose Deaths by Intent North Carolina Residents, 1999-2014 1,306 1,064 203 38 0 200 400 600 800 1,000 1,200 1,400 Numberofdeaths All intents Unintentional Self-inflicted Undetermined Assault
  • 38. Source: N.C. State Center for Health Statistics, Vital Statistics-Deaths, 1999-2014 Analysis by Injury Epidemiology and Surveillance Unit Substances Contributing to Medication or Drug Overdose Deaths North Carolina Residents, 1999-2014 684 202 246 0 100 200 300 400 500 600 700 800 900 Numberofdeaths Prescription Opioid Cocaine Heroin
  • 39. NC Heroin Deaths: 2008-2015* Source: N.C. State Center for Health Statistics, Vital Statistics-Deaths, 2008- 2015* *2015 data are provisional and likely increase as cases are finalized Analysis by Injury Epidemiology and Surveillance Unit 554% increase from 2010 to 2014 63 75 37 76 147 179 246 174 0 50 100 150 200 250 300 2008 2009 2010 2011 2012 2013 2014 2015*
  • 40.
  • 41.
  • 42. Heroin Hosp. and ED Overdoses: 2008-2014 Source: N.C. State Center for Health Statistics, Vital Statistics-Hospital Discharge 2008- 2013 NC DETECT- Statewide ED Visit data, 2008-2014 Analysis by Injury Epidemiology and Surveillance Unit 213 252 213 311 474 643 1,127 76 75 58 101 122 195 0 200 400 600 800 1000 1200 2008 2009 2010 2011 2012 2013 2014 ED Hosp From 2010 to 2014 a 429% increase for ED visits
  • 43. Recent Publications on Heroin Increases
  • 45. Heroin/Clenbuterol Cases Virginia March 2015 • 15 cases reported • Collaboration between state health, poison, health facility and law enforcement • Exchange of information and lessons learned • Recent presentations and pending publication
  • 47. Clenbuterol • A Beta-2-agonist, veterinary medication (horses) • Side effects – Tachycardia, palpitations, hypokalemia, hypotension, elevated lactate, metabolic acidosis • Drug of abuse among athletes • Inexpensive, readily available (websites)
  • 48. Heroin/Clenbuterol • Reports from the field mentioned both dealers diluting and dealers adding for euphoric effect • Recently, IVPB connected with community users – Most mentioned that it was intentional and meant to mimic a ‘speedball’ (cocaine/heroin) • Users mention ‘blue heroin’ in reports
  • 49. Reports from Users Person 1 "I have been talking about this with a group of people. Scramble is a mix they have in the Baltimore area – very different from this blue (seems to be synthetic) dope. I have a person working on finding out about this.....we think its a product of the deep web, more info as I get it."
  • 50. Reports from Users Person 2 I actually talked to someone…about this and I was saying that I didn't think it was actual dope (the blue stuff). It just wouldn't make sense...I'd think that'd stop people from buying it. I know that I wouldn't buy dope that was blue. Research chem makes sense. I thought research chem makers had had a hard time creating an opioid version over the years, but it does make sense that they'd eventually get there.
  • 51. Reports from Users Person 3 In Baltimore there are two types of heroin: scramble and raw. Raw is hard rocks and is usually sold in tiny glass vials or by weight. Scramble is usually packed into gel caps (looks like a gel cap Advil, for example). I've also never seen blue scramble. It's usually light, light brown or white. I'd think that what the guy is talking about is a local issue and not a larger thing.
  • 52. Reports from Users Person 3 Scramble is usually cut with all kinds of things. I hated it but some people love it because the rush is different - I always thought the rush sucked. I've never seen scramble down here or even in DC, but that doesn't mean it isn't. It wouldn't surprise me if people get sick off of it. It's seriously cut with whatever is around that may or may not have some sort of effect on the rush.
  • 53. Reports from Users Person 4 Yeah, a bunch of my friends have started doing it recently. It feels like fentanyl but just keeps getting stronger and stronger. I don’t know what the f**k it is but its heavy man... Like people are overdosing left and right. :/ I'll look into it, one of the big guys here in Wilmington is mainly selling it. I'll talk to her. Let you know more when I do!
  • 54. 7/7/2015, 6pm Email from Carolina Poison Control-report of ‘possible’ heroin/clenbuterol 7/8/2015, 7am IVPB sends soft ‘alert’ email sent to overdose community and Epi Section. MMRW/Hoffman 7/9/2015, 3pm What is IVPB ‘investigation process’? (3-5 possible cases) 7/9/2015, 5pm Senior leadership looped in and asked for IVPB response 7/9/2015 Reporting hospital developing case definition/survey (additional cases reported) 7/9/2015 Waiting for lab confirmation, most leaving against medical advice (AMA) 7/9/2015, 6pm NC should send out media alert (based on 2-7 cases) 7/9/2015, 6pm NC should send out media alert (based on 2-7 cases) 7/10/2015, 9am State Epi asking for update on communication/ media alert 7/10/2015, 4pm Carolina Poison Center sends out media alert (9 cases) 7/11/2015 Handful of media outlets pick up alert 7/15/2015 10 cases reported to date, several pending/some outlying counties but connection with reporting county 7/17-7/19/2015 New potential cases reported 7/19/2015 CDC Epi-X alert (18-cases) 7/20/2015 NC HAN/Letter to providers (18 cases) NC Heroin/Clenbuterol Timeline, 2015
  • 56. NC Health Alert Network (NC HAN)
  • 59. NC Heroin/Clenbuterol Cases by Date, 2015 0 1 2 3 4
  • 61. Development of Injury Warning • IVPB had new role in response • IVPB ‘thin’ bench and lack of response experience – Must coordinate with others • Several debriefings with key partners • Creation of Early Injury Warning system • IVPB staff added to NC HAN, Situation Report lists • Asked to expand our role
  • 62. NC Injury Warning Communication Protocol 1. Activation 2. Investigation/ Monitoring 3. Communication
  • 63. Small Test, January-February 2016 • Carolinas Poison Control emailed 1/22/16 with reported ‘possible’ new case in central NC (same facility as July) • Within 24 hours – All informal alerts were sent – sit.report sent to senior leadership, affected areas • Monitoring: No additional cases reported
  • 64. NC Situation Report (Sit. Report)
  • 66. North Carolina Injury and Violence Prevention Branch, Partners Poisoning Death Study Comprehensive Community Approach Chronic Pain Initiative Opioid Death Task Force Policy and Practice Research North Carolina Prevention and Harm Reduction Drug Take Back Prescription Drug Substance Abuse SAC Poisoning/Overdose Team Communication, Policy, and Advocacy Enforcement SBI and Medical & Pharm Board DPH, DMA, DMH/DD/SAS, ORH Carolinas Poison Center Monitoring Program
  • 67. Partners • NC Public Health Preparedness and Response • State Bureau of Investigation (SBI) Information Sharing and Analysis Center (ISAAC) • DPH Epi Section – Communicable diseases, food borne diseases, etc. • Clinical providers in ED (toxicologists) • Expanded relationship with Carolinas Poison Center
  • 69. NC DETECT / ED Data Mandate GS § 130A-480 (a) For the purpose of ensuring the protection of the public health, the State Health Director shall develop a syndromic surveillance program for hospital emergency departments in order to detect and investigate public health threats that may result from (i) a terrorist incident using nuclear, biological, or chemical agents or (ii) an epidemic or infectious, communicable, or other disease. The State Health Director shall maintain the confidentiality of the data reported pursuant to this section and shall ensure that adequate measures are taken to provide system security for all data and information. The State Health Director may share data with local health departments for public health purposes, and the local health departments are bound by the confidentiality provisions of this section. The State Health Director shall not allow information that it receives pursuant to this section to be used for commercial purposes and shall not release data except as authorized by other provisions of law. *Effective 1/1/2005 *Law modified in 2007 to allow sharing of reported hospital ED data with CDC
  • 70. NC DETECT Overdose Visits Source: North Carolina NC DETECT
  • 71. Access to NC DETECT • NC DETECT web application access for – Local Health Departments – Data Providers (Hospitals, EMS, Poison Center) • Authorized users are able to view data from – Emergency Departments – Carolinas Poison Center – Pre-hospital Medical Information System (PreMIS) • Training webinars provided by DPH, NC DETECT • Datasets shared with researchers after DUA and IRB approval
  • 72. Hot Topics Dashboard Click on a point to access line listing
  • 73. Reach Back Mode • When authorized, NC DPH can review medical records • Reach back mode been utilized in 2 overdose situations – TTP (Opana ER, IDU): 12 hospitalizations in TN – Heroin/Clenbuterol • Use of NC DETECT to find general heroin cases can then be retrospectively reviewed to see if there are other indications of adulteration (heart palpitations, X, Y, Z) • OR during outbreak to potentially find additional cases meeting definition
  • 75. Evaluation of Protocol • What triggers an activation? • Who initiates first alert to activate the protocol? • Who receives the notice? – Most effective communication channel for each target population? – How to best reach most at risk in shortest time? • How much time does it take to go from first alert to a communication notice?
  • 76. Evaluation of Protocol • Balancing potential public panic vs. responsibility to alert of injury dangers • When to consider “case closed”? • Expanding NC State Injury Prevention Program – Always prevention, increasingly reactive
  • 77. NC’S NEXT STEPS… CDC Prescription Drug Overdose (PDO) Prevention for States (PfS)
  • 78.
  • 79. For more information… Scott Proescholdbell, MPH scott.proescholdbell@dhhs.nc.gov Nidhi Sachdeva, MPH nidhi.sachdeva@dhhs.nc.gov Injury and Violence Prevention Branch NC Division of Public Health www.injuryfreenc.ncdhhs.gov | www.injuryfreenc.org
  • 80. Community Responses to Heroin: North Carolina and Northern Kentucky Presenters: • Kim Moser, Director, Northern Kentucky Office of Drug Control • Scott Proescholdbell, MPH, Epidemiologist, Injury and Violence Prevention Branch, North Carolina Department of Health and Human Services • Nidhi Sachdeva, MPH, Injury Prevention Consultant, Division of Public Health, North Carolina Department of Health and Human Services Heroin Track Moderator: Kelly J. Clark, MD, MBA, FASAM, DFAPA, President-elect, American Society of Addiction Medicine, and Member, Rx and Heroin Summit National Advisory Board